| Posting of Annual Report & Notice of AGM | 24-Apr-2026 | 15:16 | RNS |
| Results for the year ended 31 December 2025 | 13-Apr-2026 | 07:00 | RNS |
| Notice of Results | 07-Apr-2026 | 07:01 | RNS |
| Appointment of Nominated Adviser and Joint Broker | 07-Apr-2026 | 07:00 | RNS |
| Block Listing Return | 01-Apr-2026 | 07:00 | RNS |
| Monument Therapeutics MT1988 First Patient Dosed | 11-Mar-2026 | 07:00 | RNS |
| Monument Therapeutics MT1988 First Patient Dosed | 11-Mar-2026 | 07:00 | RNS |
| Commercialisation Agreement | 16-Feb-2026 | 07:00 | RNS |
| Change of Joint Broker | 09-Feb-2026 | 07:00 | RNS |
| Trading Update | 19-Jan-2026 | 07:00 | RNS |
| Change of Auditor | 05-Nov-2025 | 07:01 | RNS |
| Board Updates | 05-Nov-2025 | 07:00 | RNS |
| Block Listing Return | 01-Oct-2025 | 07:00 | RNS |
| Exercise of Options and Total Voting Rights | 29-Sep-2025 | 07:00 | RNS |
| Holding(s) in Company | 26-Sep-2025 | 09:59 | RNS |
| Currency | UK Pounds |
| Share Price | 35.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 36.00 |
| 52 Week Low | 35.00 |
| Volume | 56,733 |
| Shares Issued | 46.63m |
| Market Cap | £16.32m |
| Beta | 0.00 |
| RiskGrade | 282 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 1 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 2 |

| No dividends found |
| Time | Volume / Share Price |
| 09:35 | 25,000 @ 35.80p |
| 09:34 | 25,000 @ 35.40p |
| 08:29 | 305 @ 35.00p |
| 08:03 | 1,428 @ 35.00p |
| 08:02 | 5,000 @ 36.00p |
| Chair | Steven John Powell |
| CEO | Rob Baker |
| CFO | Ronald Openshaw |
You are here: research